Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.
- DOI
- 10.1111/cts.12977
- Published
- 2021-02-02
- Container
- Clin Transl Sci
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cts.12977,
title = {Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.},
author = {Kessler JA and Shaibani A and Sang CN and Christiansen M and Kudrow D and Vinik A and Shin N and VM202 study group.},
year = {2021},
journal = {Clin Transl Sci},
doi = {10.1111/cts.12977},
url = {https://doi.org/10.1111/cts.12977}
}RIS
TY - JOUR TI - Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. AU - Kessler JA AU - Shaibani A AU - Sang CN AU - Christiansen M AU - Kudrow D AU - Vinik A AU - Shin N AU - VM202 study group. PY - 2021 JO - Clin Transl Sci DO - 10.1111/cts.12977 UR - https://doi.org/10.1111/cts.12977 ER -
APA
JA, K., A, S., CN, S., M, C., D, K., A, V., N, S., & group., V. S. (2021). Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.. Clin Transl Sci. https://doi.org/10.1111/cts.12977
Source records
- europe-pmc · retrieved 2026-09-26T04:59:52.100Z